Choline salts of succinic acid for the treatment of depression, anxiety, schizophrenia, sleep disorder, and epilepsy
AssigneeIgor Anatolievich Pomytkin
InventorIgor Anatolievich Pomytkin
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods for treatment of depression, anxiety, schizophrenia, sleep disorder, or epilepsy comprising monocholine salt of succinic acid of a formula (I) or a pharmaceutically acceptable salt thereof. Preferably, the pharmaceutically acceptable salt is dicholine salt of succinic acid of a formula (II).
Claims12
A method of treating depression, anxiety, schizophrenia, sleep disorder, or epilepsy comprising administering to a mammal in need thereof an effective amount of monocholine salt of succinic acid of a formula (I)
- or a pharmaceutically acceptable salt thereof.
The use of monocholine salt of succinic acid of a formula (I)
- or a pharmaceutically acceptable salt thereof for manufacturing a pharmaceutical composition for treating depression, anxiety, schizophrenia, sleep disorder, or epilepsy in a mammal in need thereof.
A pharmaceutical composition for treating depression, anxiety, schizophrenia, sleep disorder, or epilepsy comprising (a) monocholine salt of succinic acid of a formula (I)
- or a pharmaceutically acceptable salt thereof and (b) a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.